Optimization of the PCR-SSP methodology in the identification of TNF and IL2 genetic polymorphisms;Otimização de metodologia PCR-SSP para identificação de polimorfismos genéticos de tnf e IL2

Revista Brasileira de Hematologia e Hemoterapia

Volumn 31, Issue 4, 2009, Pages 241-246

  Franceschi, Danilo A S ^a   Viel, Dangelo O ^b   Sell, Ana Maria ^b   Tsuneto, Luiza T ^b   Visentainer, Jeane E L ^b  

^a Farmacêutico Bioquímico do Laboratório de Histocompatibilidade   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Cytokines; IL2; Methodology; Single nucleotide polymorphisms; TNF

Indexed keywords

EID: 77952648303     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-84842009005000055     Document Type: Article

References (36)

1. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56(7):481-90.
2. Stoycheva MV, Murdjeva MA. Cytokines in Salmonella infections. Folia Med (Plovdiv). 2004;46(4):5-10.
3. Scheller J, Ohnesorge N, Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol. 2006; 63 (5):321-9.
4. Mathur A, Baz M, Staples ED, Bonnell M, Speckman JM, Hess PJ Jr, et al. Cytokine profile after lung transplantation: correlation with allograft injury. Ann Thorac Surg. 2006;81(5):1844-9.
5. Visentainer JE, Lieber SR, Persoli LB, Vigorito AC, Aranha FJ, de Brito Eid KA, et al. Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation. Exp Hematol. 2003;31(11):1044-50.
6. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997;94(7):3195-9.
7. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997; 24 (1):1-8.
8. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factorbeta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation. 1998;66(8):1014-20.
9. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102(7):1369-76.
10. John S, Turner D, Donn R, Sinnott P, Worthington J, Ollier WE, et al. Two novel biallelic polymorphisms in the IL-2 gene. Eur J Immunogenet. 1998;25(6):419-20.
11. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet. 1999;26(1):1-3.
12. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet. 1992;1(5):353.
13. Franceschi DS, Mazini PS, Rudnick CC, Sell AM, Tsuneto LT, Ribas ML, et al. Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil. Int J Infect Dis. 2009;13(4):493-8.
14. Maxwell JR, Potter C, Hyrich KL; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate, Barton A, Worthington J, et al. Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis. Hum Mol Genet. 2008;17(22):3532-8.
15. Manchanda PK, Mittal RD. Analysis of cytokine gene polymorphisms in recipient's matched with living donors on acute rejection after renal transplantation. Mol Cell Biochem. 2008; 311 (1-2):57-65.
16. Cho JH, Huh S, Kwon TG, Choi JY, Hur IK, Lee EY, et al. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with chronic allograft nephropathy and graft survival in Korean renal transplant recipients. Transplant Proc. 2008;40(7):2355-60.
17. Laguila Visentainer JE, Lieber SR, Lopes Persoli LB, Dutra Marques SB, Vigorito AC, Penteado Aranha FJ, et al. Relationship between cytokine gene polymorphisms and graft-versus-host disease after allogeneic stem cell transplantation in a Brazilian population. Cytokine. 2005;32(3-4):171-7.
18. Viel DO, Tsuneto LT, Sossai CR, Lieber SR, Marques SB, Vigorito AC, et al. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. Scand J Immunol. 2007;66(6):703-10.
19. Tsuneto LT, Visentainer JE, Cavichioli AG, Conçani AP, Silva GC, Sell AM, et al. TNF-A (308G/A), IL-6 (1174C/G), IFN- Gamma (874T/A), IL-10 (1082 G/A, 819C/T, 592C/A), and TGF-B1 (+869T/C,+915G/C) genotype frequencies in the Caucasoid and Mulatto Brazilian populations. Tissue Antigens 2005;66:569-9.
20. Visentainer JE, Sell AM, da Silva GC, Cavichioli AD, Franceschi DS, Lieber SR, et al. TNF, IFNG, IL6, IL10 and TGFB1 gene polymorphisms in South and Southeast Brazil. Int J Immunogenet. 2008;35(4-5):287-93.
21. Reynard MP, Turner D, Navarrete CV. Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleukin10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK. Eur J Immunogenet. 2000;27 (4):241-9.
22. Cytokine Gene Polymorphism. In: Hansen JA, Dupont B, editor. HLA 2006: Immunobiology of the Human MHC. Proceedings of the 13th International Histocompatibility Workshop and Conference. Seattle (WA): IHWG Press; 2006.
23. Roxo VMMS. Estudo de associação entre as variantes dos genes HLA-DQA1, HLA-DQB1, TNF, LTA e FAS e o pênfigo foliáceo endêmico [dissertação]. Curitiba: Departamento de Genética, Universidade Federal do Paraná, 2003.
24. Fanning GC, Bunce M, Black CM, Welsh KI. Polymerase chain reaction haplotyping using 3' mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin alpha. Tissue Antigens. 1997;50(1):23-31.
25. Reich K, Mössner R, König IR, Westphal G, Ziegler A, Neumann C. Promoter polymorphisms of the genes encoding tumor necrosis factor-alpha and interleukin-1beta are associated with different subtypes of psoriasis characterized by early and late disease onset. J Invest Dermatol. 2002;118(1):155-63.
26. Wang L, Chen RF, Liu JW, Yu HR, Kuo HC, Yang KD. Implications of dynamic changes among tumor necrosis factor-alpha (TNF- alpha), membrane TNF receptor, and soluble TNF receptor levels in regard to the severity of dengue infection. Am J Trop Med Hyg. 2007;77(2):297-302.
27. Bien E, Balcerska A. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review. Biomarkers. 2008; 13 (1):1-26.
28. Mocellin S, Nitti D. TNF and cancer: the two sides of the coin. Front Biosci. 2008;13:2774-83.
29. Ritchie D, Seconi J, Wood C, Walton J, Watt V. Prospective monitoring of tumor necrosis factor alpha and interferon gamma to predict the onset of acute and chronic graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11(9):706-12.
30. Zúñiga J, Vargas-Alarcón G, Hernández-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J. Tumor necrosis factor- alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun. 2001;2(7):363-6.
31. Lu LP, Li XW, Liu Y, Sun GC, Wang XP, Zhu XL, et al. Association of -238G/A polymorphism of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection in Chinese Han population. World J Gastroenterol. 2004;10(12): 1810-4.
32. Roxo VM, Pereira NF, Pavoni DP, Lin MT, Hansen JA, de O Poersch C, et al. Polymorphisms within the tumor necrosis factor and lymphotoxin-alpha genes and endemic pemphigus foliaceus -are there any associations? Tissue Antigens. 2003;62 (5):394-400.
33. Hoffmann SC, Stanley EM, Darrin Cox E, Craighead N, DiMercurio BS, Koziol DE, et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28- stimulated peripheral blood lymphocytes. Transplantation. 2001;72(8):1444-50.
34. Matesanz F, Fedetz M, Leyva L, Delgado C, Fernández O, Alcina A. Effects of the multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression. J Neuroimmunol. 2004; 148 (1-2):212-7.
35. Saruhan-Direskeneli G, Biçakçigil M, Yilmaz V, Kamali S, Aksu K, Fresko I, et al. Rheumatology Education and Research Society Vasculitis Study Group. Interleukin (IL)-12, IL-2, and IL-6 gene polymorphisms in Takayasu's arteritis from Turkey. Hum Immunol. 2006;67(9):735-40.
36. MacMillan ML, Radloff GA, Kiffmeyer WR, DeFor TE, Weisdorf DJ, Davies SM. High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation. Transplantation. 2003;76 (12): 1758-62.